313 related articles for article (PubMed ID: 9622067)
21. Detailed deletion mapping of chromosome 6q in borderline epithelial ovarian tumors.
Rodabaugh KJ; Blanchard G; Welch WR; Bell DA; Berkowitz RS; Mok SC
Cancer Res; 1995 May; 55(10):2169-72. PubMed ID: 7743519
[TBL] [Abstract][Full Text] [Related]
22. Identification of a 1300 kilobase deletion unit on chromosome 7q31.3 in invasive epithelial ovarian carcinomas.
Edelson MI; Scherer SW; Tsui LC; Welch WR; Bell DA; Berkowitz RS; Mok SC
Oncogene; 1997 Jun; 14(24):2979-84. PubMed ID: 9205105
[TBL] [Abstract][Full Text] [Related]
23. Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of synchronous ovarian and fallopian tube mucosal serous carcinoma.
Salvador S; Rempel A; Soslow RA; Gilks B; Huntsman D; Miller D
Gynecol Oncol; 2008 Sep; 110(3):408-17. PubMed ID: 18597838
[TBL] [Abstract][Full Text] [Related]
24. Altered expression and loss of heterozygosity of the LOT1 gene in ovarian cancer.
Cvetkovic D; Pisarcik D; Lee C; Hamilton TC; Abdollahi A
Gynecol Oncol; 2004 Dec; 95(3):449-55. PubMed ID: 15581945
[TBL] [Abstract][Full Text] [Related]
25. Frequent down-regulation and lack of mutation of the KAI1 metastasis suppressor gene in epithelial ovarian carcinoma.
Liu FS; Dong JT; Chen JT; Hsieh YT; Ho ES; Hung MJ
Gynecol Oncol; 2000 Jul; 78(1):10-5. PubMed ID: 10873402
[TBL] [Abstract][Full Text] [Related]
26. Androgen receptor gene methylation and exon one CAG repeat length in ovarian cancer: differences from breast cancer.
Kassim S; Zoheiry NM; Hamed WM; Going JJ; Craft JA
IUBMB Life; 2004 Jul; 56(7):417-26. PubMed ID: 15545219
[TBL] [Abstract][Full Text] [Related]
27. Chromosome 6 abnormalities in ovarian surface epithelial tumors of borderline malignancy suggest a genetic continuum in the progression model of ovarian neoplasms.
Tibiletti MG; Bernasconi B; Furlan D; Bressan P; Cerutti R; Facco C; Franchi M; Riva C; Cinquetti R; Capella C; Taramelli R
Clin Cancer Res; 2001 Nov; 7(11):3404-9. PubMed ID: 11705855
[TBL] [Abstract][Full Text] [Related]
28. Clonal origin of lymph node metastases in bladder carcinoma.
Jones TD; Carr MD; Eble JN; Wang M; Lopez-Beltran A; Cheng L
Cancer; 2005 Nov; 104(9):1901-10. PubMed ID: 16196038
[TBL] [Abstract][Full Text] [Related]
29. Evidence for common clonal origin of multifocal lung cancers.
Wang X; Wang M; MacLennan GT; Abdul-Karim FW; Eble JN; Jones TD; Olobatuyi F; Eisenberg R; Cummings OW; Zhang S; Lopez-Beltran A; Montironi R; Zheng S; Lin H; Davidson DD; Cheng L
J Natl Cancer Inst; 2009 Apr; 101(8):560-70. PubMed ID: 19351924
[TBL] [Abstract][Full Text] [Related]
30. Microinvasion links ovarian serous borderline tumor and grade 1 invasive carcinoma.
Hogg R; Scurry J; Kim SN; Friedlander M; Hacker N
Gynecol Oncol; 2007 Jul; 106(1):44-51. PubMed ID: 17467045
[TBL] [Abstract][Full Text] [Related]
31. [Diagnostic difficulties in serous "borderline" tumors of the ovary].
Vereczkey I; Tóth E; Orosz Z
Magy Onkol; 2009 Mar; 53(1):23-31. PubMed ID: 19318323
[TBL] [Abstract][Full Text] [Related]
32. Unifocal origin of advanced human epithelial ovarian cancers.
Mok CH; Tsao SW; Knapp RC; Fishbaugh PM; Lau CC
Cancer Res; 1992 Sep; 52(18):5119-22. PubMed ID: 1516069
[TBL] [Abstract][Full Text] [Related]
33. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
[TBL] [Abstract][Full Text] [Related]
34. Allelotyping defines minimal imbalance at chromosomal region 17q25 in non-serous epithelial ovarian cancers.
Dion F; Mes-Masson AM; Seymour RJ; Provencher D; Tonin PN
Oncogene; 2000 Mar; 19(11):1466-72. PubMed ID: 10723138
[TBL] [Abstract][Full Text] [Related]
35. Interphase cytogenetic analysis of serous ovarian tumors of low malignant potential: comparison with serous cystadenomas and invasive serous carcinomas.
Diebold J; Deisenhofer I; Baretton GB; Blasenbreu S; Suchy B; Schneiderbanger K; Meier W; Haas CJ; Löhrs U
Lab Invest; 1996 Oct; 75(4):473-85. PubMed ID: 8874380
[TBL] [Abstract][Full Text] [Related]
36. Microdissection-based mutational genotyping of serous borderline tumors of the ovary.
Krishnamurti U; Sasatomi E; Swalsky PA; Jones MW; Finkelstein SD
Int J Gynecol Pathol; 2005 Jan; 24(1):56-61. PubMed ID: 15626917
[TBL] [Abstract][Full Text] [Related]
37. Mapping of chromosome 3p deletions in human epithelial ovarian tumors.
Lounis H; Mes-Masson AM; Dion F; Bradley WE; Seymour RJ; Provencher D; Tonin PN
Oncogene; 1998 Nov; 17(18):2359-65. PubMed ID: 9811467
[TBL] [Abstract][Full Text] [Related]
38. A molecular genetic and statistical approach for the diagnosis of dual-site cancers.
Brinkmann D; Ryan A; Ayhan A; McCluggage WG; Feakins R; Santibanez-Koref MF; Mein CA; Gayther SA; Jacobs IJ
J Natl Cancer Inst; 2004 Oct; 96(19):1441-6. PubMed ID: 15467033
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of the micropapillary pattern in patients with serous borderline ovarian tumors.
Chang SJ; Ryu HS; Chang KH; Yoo SC; Yoon JH
Acta Obstet Gynecol Scand; 2008; 87(4):476-81. PubMed ID: 18382877
[TBL] [Abstract][Full Text] [Related]
40. Borderline ovarian tumors and fertility.
Nam JH
Curr Opin Obstet Gynecol; 2010 Jun; 22(3):227-34. PubMed ID: 20386444
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]